baber/WOPTO huggingface dataset:
Patent NZ-190350-A (NZ)
Title: Method and apparatus for stimulating immunological and resistance response in mammary glands
Inventor: KORTUM W M
IPC: A61D7/00
Filed: 1979-05-03
Abstract: Process and apparatus (see figure 2) are provided for stimulating immune resistance by the introduction of at least one relatively small solid non-toxic substantially non-biodegradable body (22), having nonspecific antigenic action, into each gland cistern of the udder. The body is sufficiently flexible or elastic and of a shape so as to be capable of being shaped into a form small enough to be inserted into the gland cistern through the lactiferous duct and then reformed to its original shape which inhibits its passage from the gland cistern into the teat cistern. The continued presence of the non-specific antigenic body induces immune resistance including an increase in the number and activity of phagocytic cells, particularly leukocyte cells, in the udder.The continued presence of these increased numbers of activated phagocytic cells provides protection against bacterial invasion through the streak canal without degrading milk quality
Patent NZ-202691-A (NZ)
Title: Derivatives of 2-(-oxyiminoalkyl)-3-hydroxy-5-thiophenyl cyclohex-2-en-1-one
Inventor: SERBAN A
IPC: A01N35/10
Filed: 1982-12-03
Abstract: The invention concerns novel compounds of the formula Iwherein:R' is selected from alkyl, alkenyl, alkynyl, cycloalkyl benzyl and substituted benzyl;A is selected from hydrogen, halogen, nitro, alkyl, alkoxy, alkylthio, alkenylthio, alkynylthio, cycloalkoxy, cycloalkylthio, sulfamoyl, N-(C<sub>1</sub> to C<sub>6</sub> alkyl) sulfamoyl, N,N-di(C<sub>1</sub> to C<sub>6</sub> alkyl) sulfamoyl, benzylthio and substituted benzylthio;R<sup>2</sup> is selected from hydrogen, alkyl, alkenyl, alkynyl, substituted alkyl, acyl, alkylsulfonyl, benzenesulfonyl, substituted benzenesulfonyl, and an inorganic or organic cation;R<sup>3</sup> is selected from alkyl, alkenyl, alkynyl, substituted alkyl, haloalkenyl and haloalkynyl; andR" is selected from alkyl, fluoroalkyl, alkenyl, alkynyl and phenyl.The compounds are herbicides and in further embodiments the invention provides processes for the preparation of compounds of formula I, intermediates useful in the preparation of compounds of formula I, herbicidal compositions containing as active ingredient a compound of formula I, and processes for severely damaging or killing unwanted plants by applying to the plants or to the growth medium of the plants an effective amount of a compound of formula I.
Patent NZ-218118-A (NZ)
Title: Liquid detergent compositions with a mixture of anionic, polymeric and betaine surfactants
Inventor: PANCHERI EUGENE JOSEPH
IPC: C11D1/66
Filed: 1986-10-30
Abstract: High sudsing liquid detergent compositions contain anionic surfactant, polymeric surfactant which contains either linkages and a betaine surfactant for improved grease handling.
Patent NZ-247670-A (NZ)
Title: Heterogenous, hydrophobic polysulphone hollow fiber membrane, preparation and use in a dialyzer for filtering human body fluid
Inventor: CHU CHAOKANG
IPC: B01D67/00
Filed: 1993-05-21
Abstract: A morphologically heterogenous, hydrophobic polysulfone hollow fiber membrane comprising a sponge-like dense inner surface permeable to molecules of less than or equal to 30,000 Daltons, said inner surface having a fractional surface porosity from 70 to 80%, and an outer surface having large pores from 6 to 16 mu m in diameter and small pores less than 500 ANGSTROM  in diameter and a fractional surface porosity from 20 to 30%; a method for producing same and a hemodialysis treatment method and apparatus incorporating same.
Patent NZ-264556-A (NZ)
Title: Tissue factor enclosed in a phospholipid vesicle or micelle, method of preparation
Inventor: BROWN SCOTT MARTIN
IPC: A61K9/127
Filed: 1991-11-13
Abstract: Prothrombin time reagents are provided which comprise novel liposome compositions in which tissue factor is associated with an inserted into the phospholipid bilayer of the liposomes. Methods for their preparation are also provided. The liposome compositions may be adjusted to allow maximum coagulant activity and sensitivity to extrinsic coagulation factors.
Patent NZ-270444-A (NZ)
Title: 3-aminoethyl-4-benzoyl-1,4-benzoxazine derivatives and medicaments
Inventor: GEORGE PASCAL
IPC: A61K31/38
Filed: 1995-02-02
Abstract: Benzoxazine derivs. of formula (I) and their optical isomers and acid-addn. salts are new. R1 = H, F, Cl, Me, 1-3C alkoxy or NO2; R3 = H or 1-3C alkyl; R4 = 2,3-dihydro-1H-inden-2-yl, 2,3-dihydro-1H-inden-1-yl or 1,2,3,4-tetrahydronaphthalen-1-yl; or NR3R4 = 1,2,3,4-tetrahydro- 9H-pyrido(3,4-b)indol-2-yl, 1,2,3,4-tetrahydro- 9H-pyrido(4,3-b)indol-3-yl, 4,5,6,7-tetrahydro- thieno(2,3-c)pyridin-6-yl, 4,5,6,7-tetrahydro- thieno(3,2-c)pyridin-6-yl or 2,3-dihydro-1H-isoindol-2-yl.
Patent NZ-280224-A (NZ)
Title: Noise suppression in sampled speech: digital sampling with time filter coeffiecients
Inventor: BOURMEYSTER IVAN
IPC: G10L21/02
Filed: 1995-10-12
Abstract: The method involves applying noisy input speech signals (S(t)) to a sampler (1a). The signal is divided, with part of the signal passed to a noisy signal processor (100). The processor extracts noisy energy signals (10) and passes them to an S/N ratio estimator (11). The signal is then passed to a gain calculation circuit (12) before input to a circuit determining the filter function coefficient. The output C(nT) from the filter function circuit is applied to a FIR filter (14) in the second channel.
Patent NZ-331464-A (NZ)
Title: Free radical polymer chain initiation with unreactive unsaturates
Inventor: ITTEL STEVEN DALE
IPC: C08F2/38
Filed: 1997-03-19
Abstract: This invention relates to a method by which olefinically-unsaturated organic molecules, which are otherwise nonpolymerizable, may be homopolymerized or copolymerized with conventional monomers through the use of cobalt chain transfer catalysts. The resulting macromonomers contain one terminal functional group and a terminal double bond on the other end of the chain.
Patent NZ-332506-A (NZ)
Title: Alkaline aqueous hard surface cleaning compositions containing a glycol ether solvent system and a nonionic surfactant
Inventor: FENG JAMES CHI-CHENG
IPC: C11D3/33
Filed: 1997-05-20
Abstract: An alkaline hard surface cleaning composition is claimed comprising: a) 0.01-0.85 wt.% of a non-ionic surfactant compound based on an amine oxide; b) 0-1.5 wt.% of a chelating agent; c) 0.01-2.5 wt.% of caustic; d) 3.0-9.0 wt.% of a glycol ether solvent system; e) 0-5.0 wt.% of a water soluble amine containing organic compound; f) 0-2.5 wt.% of a soil anti-redeposition agent and g) 0-2.5 wt.% of optional constituents. The glycol ether solvent system comprising: i) one glycol ether or glycol ether acetate solvent having a solubility in water of not more than 20 wt.% and ii) a second glycol ether or glycol ether acetate having a solubility of approximately 100 wt.% wherein the ratio of the former to the latter is from 0.5:1 to 1.5:1 The composition includes no more than 10 wt.% of volatile organic constituents.  Methods for the use of the cleaning composition and processes for itsr production are also claimed.
Patent NZ-337338-A (NZ)
Title: Aerosol dispenser and cartridge
Inventor: MILLER ALLEN D
IPC: B65D83/38
Filed: 1997-08-28
Abstract: An aerosol dispenser (10) and a refill cartridge (18) therefor. The aerosol dispenser (18) has an outer housing (12) adapted to preferentially fit a user's hand with the front (14) of the dispenser (10) presented away from the user. An actuator arm (52) is hinged to the outer housing (12). A refill cartridge may be removably inserted into the outer housing (12) from beneath. The cartridge (38) includes an aerosol can (18) having a manually activatable valve (28) and an upwardly directed nozzle (20), which extends through a nozzle port in the actuator arm (52) when the cartridge (38) is inserted within the outer housing (12). A user can activate the valve (28) by hand by pushing the actuator arm (52) downwardly with a finger. The outer housing (12) is designed to be held on a level surface during such activation. The nozzle (20) includes a longitudinally extended delivery tube (22) in fluid communication with the pressurized material in the can (18). The delivery tube (22) communicates with a longitudinally extended exit chamber (24) having a spray orifice (26). The longitudinal axis of the exit chamber (24) is angularly displaced frontwardly from the longitudinal axis of the delivery tube (22).
Patent NZ-500526-A (NZ)
Title: Enantioselective addition reaction using an organozinc reagent to produce (-)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one
Inventor: TILLYER RICHARD D
IPC: C07C215/68
Filed: 1998-05-12
Abstract: A process for the preparation of a compound of formula (I) wherein: M is Li, Na, K, Zn, MgX1, CuX1, or B(X1)2; X1 is Cl, Br, I, F or CF3SO2; A is optionally substituted alkyl, alkenyl, alkynyl, phenyl, biphenyl, or naphthyl, R5 is H, optionally substituted alkyl, alkenyl, alkynyl or perfluoroalkyl, R6 is optionally substituted alkyl, alkenyl, or alkynyl comprises: a) adding slowly a dialkylzinc either neat or in a solvent to a first chiral additive bearing one or more exchangeable protons or alternatively to a mixture of a first chiral additive bearing one and only exchangeable proton and a second additive in a solvent under an inert atmosphere at a temperature of -78 OC to 50 OC to form a chiral zinc complex or a second additive containing chiral zinc complex; b) adding a second additive to a chiral zinc complex, and heating the reaction to 10 OC to 70 OC to form a second additive containing chiral zinc complex, where the first chiral additive bears one and only one exchangeable proton, or alternatively, where the first chiral additive bears more than one exchangeable proton, or the second additive was added in step a), then this addition step is skipped; c) mixing the chiral zinc complex or the second additive containing chiral zinc complex with an organometallic reagent of formula R6M in a solvent at a temperature range of -20 OC to 60 OC to form a chiral organozinc complex and d) mixing a carbonyl containing compound of formula A-C(O)-R5 optionally dissolved in a solvent with the solution of the chiral organozinc complex under an inert atmosphere at a temperature of -20 oC to 60 oC for 1 to 72 hours.
Patent NZ-502523-A (NZ)
Title: Mutations in the myostation gene cause double-muscling in mammals
Inventor: PONCELET DOMINIQUE
IPC: C12Q1/68
Filed: 1998-07-14
Abstract: A gene (cDNA) encoding a bovine myostatin protein. The nucleic acid coding sequence is identified as SEQ ID NO:1 and the protein sequence is identified as SEQ ID NO:2. A mutant gene (SEQ ID NO:3) in which the coding sequence lacks an 11-base pair consecutive sequence (SEQ ID NO:11) of the sequence encoding bovine protein having myostatin activity has been sequenced. It has been shown that cattle of the Belgian Blue breed homozygous for the mutant gene lacking myostatin activity are double-muscled. A method for determining the presence of muscular hyperplasia in a mammal is described. The method includes obtaining a sample of material containing DNA from the mammal and ascertaining whether a sequence of the DNA encoding (a) a protein having biological activity of myostatin, is present, and whether a sequence of the DNA encoding (b) an allelic protein lacking the activity of (a), is present. The absence of (a) and the presence of (b) indicates the presence of muscular hyperplasia in the mammal.
Patent NZ-503024-A (NZ)
Title: Process for rigid polyurethane foams using a blowing agent containing 1,1,1,3,3-pentafluoropropane and isopentane and/or n-pentane
Inventor: COLEMAN LUC FERDINAND LEON
IPC: C08G18/48
Filed: 1998-08-27
Abstract: A process for preparing rigid polyurethane or urethane modified polyisocyanurate foams comprises reacting an organic polyisocyanate with a polyfunctional isocyanate reactive component in the presence of water and a physical blowing agent mixture containing 1,1,1,3,3-pentafluoropropane and isopentane and/or n-pentane.  The mole ratio of 1,1,1,3,3-pentafluoropropane/isopentane and/or 1,1,1,3,3-pentafluoropropane/n-pentane is between 1-99 and 40-60.
Patent NZ-504097-A (NZ)
Title: Methods of treatment using selected derivatives of K-252a
Inventor: TANAKA RIEKO
IPC: A61K31/00
Filed: 2000-04-19
Abstract: Disclosed herein are selected indolocarbazole derivatives which are represented by general formula (I). The compounds are useful for enhancing the function and/or survival of a trophic factor responsive cell. They inhibit interleukin-2 production and have immunosuppressive activity. (62) Divided out of 333018
Patent NZ-504181-A (NZ)
Title: Planing, air-conveying bottom for boats with grooves formed with flat intermediate zones joined to boat bottom by curved portions
Inventor: MAMBRETTI RICCARDO
IPC: B63B1/20
Filed: 1998-02-18
Abstract: V-shaped bottom (94) for fast motorboats (90) that presents a number of longitudinal means substantially parallel and symmetrical to the keel having walls that react to the lateral thrust from the water-air mixture, formed either of grooves (15, 18, 91, 92) or of ribs, their sides being widely curved at the junction respectively with the base of the grooves (15, 18, 91, 92) and with the surface of the bottom (94) of the boat.
Patent NZ-507874-A (NZ)
Title: Dressing with one or more elastic sections and adhesive on one side
Inventor: BEAUDRY WALLACE J
IPC: A61F13/02
Filed: 1997-01-17
Abstract: A dressing mechanism comprising: a first section, a second section, and a third section; the first section being coupled to the second section and the second section being coupled to the third section; wherein the second section comprises an elastic material (110); and wherein said first section and the third section each include a first side; and a predetermined portion (121d) of the first side including an adhesive (121b) located thereon.
Patent NZ-513234-A (NZ)
Title: Method and apparatus for enhanced audio/video services with watermarks and associated data
Inventor: HOLLAR MARK A
IPC: H04L9/32
Filed: 2000-02-25
Abstract: A method of controlling copying of a video signal comprises supplying the video signal; embedding a watermark in the video signal; and providing associated data in a predetermined location of the video signal, the associated data such as a cryptographic value being related to the watermark in a predetermined manner. The cryptographic value can be a hash function of a seed, and the watermark is the hash function of the hash function of the hash function of the seed. An apparatus for processing an input video signal to control subsequent copying thereof, comprises: a seed generator; a hash function generator coupled to receive a seed from the seed generator and output resulting data; a watermark generator coupled to receive the seed and generate a watermark from the seed, and to embed the watermark in a picture portion of the input video; and a transmission channel coupled to transmit the resulting data and the watermarked video to a receiver, the resulting data being transmitted other than in a picture portion of the video. A video recorder, comprises: an interface to a recording medium; an input port for receiving a video signal to be recorded on the medium; a watermark detector coupled to the input port; a data detector coupled to the input port to detect data at a predetermined location in the video signal; and a processor coupled to compare the detected watermark to a compression function of the data, and to enable recording of the video signal onto the medium if the comparison is a match. A video player comprises: an interface to a recording medium which outputs a video signal; a watermark detector coupled to receive the video signal; a data detector coupled to detect a data associated with the video signal; a processor coupled to the watermark detector and data detector and which subjects the detected data to a compression function and compares the watermark to the compressed function of the data and allows further playing only if the comparison is a match. A set top box for connection to a television receiver, comprises: an input terminal adapted to receive a video signal including a watermark and to receive associated data; a conditional access control, having a control terminal for receiving a user selection for enabling recording of the video signal; and a combiner having a control terminal coupled to an output terminal of the conditional access control and receiving the video signal from the input terminal, and having an output terminal, wherein the combiner outputs the video signal with or without the associated data in response to the conditional access control.
Patent NZ-514170-A (NZ)
Title: Benzo-1, 3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
Inventor: WINN MARTIN
IPC: A61P9/00
Filed: 1997-02-12
Abstract: A process for preparing a compound of formula (I), wherein: E is a carboxy-protecting group and R1 and R2 are loweralkyl, alkoxyalkyl, alkoxycarbonylalkyl, hydroxyalkyl, haloalkyl, haloalkoxyalkyl, alkylaminocarbonylalkyl, dialkylaminocarbonylalkyl,aminocarbonyalkenyl, alkylaminocarbonylalkenyl, dialkylaminocarbonylalkenyl, aryl, arylalkyl, aryloxyalkyl, arylalkoxyalkyl, heterocyclic and (heterocyclic)alkyl Wherein cycloalkyl, aryl and heterocyclic may be optionally substituted, provided at least one of the following conditions apply: (a) R1 is selected from haloalkyl, haloalkoxyalkyl, cycloalkylalkyl, arylalkyl, aryloxyalkyl, and (heterocyclic)alkyl, (b) R2 is selected from haloalkyl, haloalkoxyalkyl, cycloalkylalkyl, arylalkyl, aryloxyalkyl, (c) at least on of the optionally substituted aryl groups has at least on substituent selected from hydroxyalkyl and cyano or (d) at least one of the optionally substituted heterocyclic groups has at least one substituent selected from alkyloxycarbonyl, nitro and cyano; comprises a) catalytic hydrogenation of a compound of Formula (II) b)catalytic hydrogenation of the product of step a) in the presence of an acid or a mixture of acids, and c) epimerization of the product of step b) with a base. Also described is the compound (2R, 3R, 4S)-(+)-2-(4-methoxyphenyl)-4-(1,3-benzodioxol-5-yl)-1-(N,N-di(n-butyl-aminocarbonylmethyl)-pyrrolidine-3-carboxylic acid. This compound can be used in the manufacture of a medicament for antagonizing endothelin treating hypertension, congestive heart failure, restinosis cerebral or myocardial ischemia or atherosclerosis, treating coronary angina, cerebral vasospasm, acute and chronic renal failure, gastric ulceration, cyclosporine-induced nephrotoxicity, endotoxin-induced toxicity, asthma, LPL-related lipoprotein disorders, proliferative diseases, acute or chronic pulmonary hypertension, platelet aggregation, thrombosis, IL-2 mediated cardio toxicity nociception, colitis, vascular permeability disorders, ischemia-reperfusion injury raynaud's disease, migraine and for treating bone pain. (62) Divided out of 503365
Patent NZ-515675-A (NZ)
Title: Novel interleukin-1 and tumor necrosis factor-alpha modulators, syntheses of said modulators and methods of using said modulators
Inventor: PALLADINO MICHAEL
IPC: C07C62/32
Filed: 2000-05-12
Abstract: A compound having the following chemical structure: -R1 is selected from the group consisting of hydrogen, a halogen, C1-C12 carboxylic acids, halides, C1-C12 acyl halides, C1-C12 acyl residues, C1 - C12 esters, C1 - C12 secondary amides, (C1-C12) (C1-C12) tertiary amides, C1-C12 alcohols, (C1-C12)(C1-C12) ethers, C1-C12 substituted alkyls, C2-C12 alkenyls, C2-C12 substituted alkenyls, and C5-C12 aryls; -R2 and R9 are each separately selected from hydrogen, a halogen, C1-C12 alkyl, C1-C12 substituted alkenyl, C2-C12 substituted alkenyl, C2-C12 alkynyl, C1-C12 alcohol, C1-C12 acyl, andC5-C) aryl; -R3-R5, R7, R8 and R11-R13 are each separately selected from hydrogen, a halogen, C1-C12 alkyl, C1-C12 substituted alkyls, C2-C12 alkenyl, C2-C12 substituted alkenyl, C2-C12 alkynyl, and C1-C12 alcohol, C1-C12 alkynyl and C5-C12 aryl; -R6 is selected from hydrogen, a halogen, C1-C12 alkyl, C1-C12 substituted alkyls, C2-C12 alkenyl, and C2-C12 alkynyl; -R10 is selected from hydrogen, a halogen, CH2, C1-C6 alkyl, C1-C6 substituted alkyl, C2-C6 alkenyl, C2-C6 substituted alkenyl, C1-C12 alcohol and C5-C12 aryl; and -R14 and R15 are separately selected from hydrogen, a halogen, C1-C6 alkyl, C1-C6 substituted alkyl, C2-C6 alkenyl, C2-C6 substituted alkenyl, C1-C6 alcohol, and C5-C6 aryl. A method of making the above described compound is disclosed. The use of the above described compound for treating conditions associated with inflammation, tuberculous pleurisy, rheumatoid pleurisy, skin redness, cancer, cardiovascular disease, diabetes, transplant rejection, otitis media, sinusitis and viral infections.
Patent NZ-520115-A (NZ)
Title: A panel and related wall structure
Inventor: TUCKER MARK IRVINE
Filed: 2002-07-11
Abstract: A unitary wall or ceiling panel comprising of a first solid layer solidified gypsum and a second layer of a solidified gypsum having a plurality cavities. The second layer is engaged with the first layer and disposed from one side thereof. The cavities each including an anhydrate material of a kind having a water content dependent volumetric displacement. The cavities have been formed by the volumetric shrinking of the anhydrate material resultant from the dissipation of water from the unitary panel gypsum wet phase precursor during its curing to a solidified state.
Patent NZ-521836-A (NZ)
Title: High pressure treatment to reduce microbial spoilage in cultured dairy foods, cooked meats, vegetables and the like
Inventor: CARROLL TIM
IPC: A23C9/123
Filed: 2002-10-08
Abstract: Methods of pressure treating food so as to reduce spoilage of the food are described. More particularly described is the use of high pressure treatment to reduce microbial spoilage in foods and/or to render the food safe for consumption, while retaining viable desired cultures. The method of treating a food comprises the following steps: selecting a food comprising at least one strain of a culture, the strain capable of surviving a pressure treatment at a predetermined pressure and pH, and, subjecting the food to a treatment pressure at or below the predetermined pressure, wherein the treatment pressure reduces, delays, prevents or eliminates growth of spoilage microflora; wherein the treatment pressure is at least 35OMPa. Preferably the food is subjected to a pressure of at least 400Mpa and the method may be performed at a pH level selected from between 3.0 and 4.7 inclusive.
Patent NZ-522110-A (NZ)
Title: Post foaming cleaning compositions
Inventor: POLLACK CHARLES A
IPC: C11D1/86
Filed: 2000-04-06
Abstract: A post foaming all-purpose cleaning composition, comprising by weight: (a) 10% to 24% of a tall oil fatty acid, (b) 2% to 10% of potassium hydroxide, (c) 0.1% to 5% of amine oxide, (d) 0.1% to 5% of a sultaine, (e) 7% to 14% of isopentane, and (f) 75% to 95% of water.
Patent NZ-522450-A (NZ)
Title: Methods for prevention of ulcers
Inventor: PIPERS FRANK
IPC: A61K31/4184
Filed: 2001-05-18
Abstract: A method for preventing occurrence of gastric ulcers in a horse about to undergo stress that causes gastric ulcers and prior to occurrence to gastric ulcer conditions in the horse. This comprises administering to the horse an effective amount of omeprazole prior to and optionally during the stress.